BioSpace News Archive

NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three and 12 months ended December 31, 2021 after market close on Tuesday, March 29, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Aravive, Inc., a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced the appointment of industry veteran, Scott Dove, Ph.D., as Chief Operating Officer.

Matinas BioPharma announced that Jerry Jabbour, Chief Executive Officer, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest.

Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Stephen O’Quinn, Vice President, Medical Affairs, Zynerba Pharmaceuticals, will participate in a panel discussion at the 2022 Cantor Rare Orphan Disease Summit taking place virtually March 29-30, 2022.

ProMIS Neurosciences, Inc. announced in vivo results of its experimental Alzheimer’s vaccine presented at the AD/PDTM International Conference held in Barcelona Spain, March 15-20, 2022.

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced that Klaus Orlinger, Ph.D. has been promoted to Chief Scientific Officer.

Cyclacel Pharmaceuticals, Inc. will announce fourth quarter and full year 2021 financial results on Monday, March 28, 2022.

Three Poster Presentations Will Include New Analyses on IDP-126 Gel, DUOBRII ® and SILIQ.

Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced that it has closed a $20 million funding round led by Evidity Health Capital and joined by existing and new investors.

Telemedicine and virtual office visits experienced exponential growth during the COVID-19 pandemic to help facilitate the safe delivery of orthopaedic care for numerous patient populations, including pediatric.